144 related articles for article (PubMed ID: 38314319)
1. A promising response of refractory uterine leiomyosarcoma to pembrolizumab and temozolomide combination therapy.
Lin R; Muaadz A; Gwo Fuang H
Gynecol Oncol Rep; 2024 Feb; 51():101326. PubMed ID: 38314319
[TBL] [Abstract][Full Text] [Related]
2. Stabilization of Metastatic Uterine Leiomyosarcoma Using Pembrolizumab.
Cotangco K; Meram M; Lowe MP
J Natl Compr Canc Netw; 2020 Aug; 18(8):1012-1014. PubMed ID: 32755974
[TBL] [Abstract][Full Text] [Related]
3. Clinical Benefit in Response to Palbociclib Treatment in Refractory Uterine Leiomyosarcomas with a Common
Elvin JA; Gay LM; Ort R; Shuluk J; Long J; Shelley L; Lee R; Chalmers ZR; Frampton GM; Ali SM; Schrock AB; Miller VA; Stephens PJ; Ross JS; Frank R
Oncologist; 2017 Apr; 22(4):416-421. PubMed ID: 28283584
[TBL] [Abstract][Full Text] [Related]
4. Temozolomide in advanced and recurrent uterine leiomyosarcoma and correlation with o6-methylguanine DNA methyltransferase expression: a case series.
Ferriss JS; Atkins KA; Lachance JA; Modesitt SC; Jazaeri AA
Int J Gynecol Cancer; 2010 Jan; 20(1):120-5. PubMed ID: 20130512
[TBL] [Abstract][Full Text] [Related]
5. Sleeping Beauty Transposon Mutagenesis Identifies Genes Driving the Initiation and Metastasis of Uterine Leiomyosarcoma.
Kodama M; Shimura H; Tien JC; Newberg JY; Kodama T; Wei Z; Rangel R; Yoshihara K; Kuruma A; Nakae A; Hashimoto K; Sawada K; Kimura T; Jenkins NA; Copeland NG
Cancer Res; 2021 Nov; 81(21):5413-5424. PubMed ID: 34475109
[TBL] [Abstract][Full Text] [Related]
6. Retrospective analysis of treatment and prognosis for uterine leiomyosarcoma: 10-year experience of a single institute.
Kodama K; Sonoda K; Kijima M; Yamaguchi S; Yagi H; Yasunaga M; Ohgami T; Onoyama I; Kaneki E; Okugawa K; Yahata H; Ohishi Y; Oda Y; Kato K
Asia Pac J Clin Oncol; 2020 Apr; 16(2):e63-e67. PubMed ID: 31721462
[TBL] [Abstract][Full Text] [Related]
7. Skull Metastasis From Uterine Leiomyosarcoma, a Rare Presentation for a Rare Tumor: A Case Report and Review of the Literature.
Rizzo A; Nigro MC; Ramponi V; Gallo C; Perrone AM; De Iaco P; Frezza G; Balestrini D; Di Benedetto M; Morbiducci J; Pantaleo MA; Nannini M
Front Oncol; 2020; 10():869. PubMed ID: 32612948
[TBL] [Abstract][Full Text] [Related]
8. Clinical status and prognostic factors in Japanese patients with uterine leiomyosarcoma.
Takehara K; Yamashita N; Watanabe R; Teramoto N; Tsuda H; Motohashi T; Harano K; Nakanishi T; Tokunaga H; Susumu N; Ueda Y; Yokoyama Y; Saito T
Gynecol Oncol; 2020 Apr; 157(1):115-120. PubMed ID: 31983515
[TBL] [Abstract][Full Text] [Related]
9. Use of pembrolizumab in MSI-high uterine leiomyosarcoma; a case report and review of the literature.
Wang YJ; Williams HR; Brzezinska BN; Gaidis A; Patel B; Munroe J; White J; Rungruang B
Gynecol Oncol Rep; 2021 Feb; 35():100701. PubMed ID: 33537390
[TBL] [Abstract][Full Text] [Related]
10. The Functional Role and Regulatory Mechanism of FTO m
Yang Q; Al-Hendy A
Int J Mol Sci; 2023 Apr; 24(9):. PubMed ID: 37175660
[TBL] [Abstract][Full Text] [Related]
11. Targeting homologous recombination deficiency in uterine leiomyosarcoma.
Dall G; Vandenberg CJ; Nesic K; Ratnayake G; Zhu W; Vissers JHA; Bedő J; Penington J; Wakefield MJ; Kee D; Carmagnac A; Lim R; Shield-Artin K; Milesi B; Lobley A; Kyran EL; O'Grady E; Tram J; Zhou W; Nugawela D; Stewart KP; Caldwell R; Papadopoulos L; Ng AP; Dobrovic A; Fox SB; McNally O; Power JD; Meniawy T; Tan TH; Collins IM; Klein O; Barnett S; Olesen I; Hamilton A; Hofmann O; Grimmond S; Papenfuss AT; Scott CL; Barker HE
J Exp Clin Cancer Res; 2023 May; 42(1):112. PubMed ID: 37143137
[TBL] [Abstract][Full Text] [Related]
12. Temozolomide in uterine leiomyosarcomas.
Anderson S; Aghajanian C
Gynecol Oncol; 2005 Jul; 98(1):99-103. PubMed ID: 15916799
[TBL] [Abstract][Full Text] [Related]
13. Long-Lasting Response to Trabectedin in a Patient with Metastatic Uterine Leiomyosarcoma: A Case Report.
Nteli VA; Knauf W; Janton-Klein A; El-Safadi S
Case Rep Oncol; 2018; 11(1):81-89. PubMed ID: 29515415
[TBL] [Abstract][Full Text] [Related]
14. A novel case of left atrial and right lung mass turned out to be unconventional metastasis of uterine leiomyosarcoma with a review of literature.
Patel T; Aswal P; Jakhetiya A; Meena V; Pandey A
Indian J Pathol Microbiol; 2023; 66(3):601-604. PubMed ID: 37530349
[TBL] [Abstract][Full Text] [Related]
15. Multimodal treatment with doxorubicin, cisplatin, and ifosfamide for the treatment of advanced or metastatic uterine leiomyosarcoma: a unicentric experience.
Hadoux J; Rey A; Duvillard P; Lhommé C; Balleyguier C; Haie-Meder C; Morice P; Tazi Y; Leary A; Larue C; Pautier P
Int J Gynecol Cancer; 2015 Feb; 25(2):296-302. PubMed ID: 25581897
[TBL] [Abstract][Full Text] [Related]
16. A Case of Uterine Leiomyosarcoma with Long-Term Disease Control by Pazopanib.
Nagamata S; Ebina Y; Yamano Y; Miyamoto T; Nishijima M; Yamada H
Kobe J Med Sci; 2016 Jul; 62(2):E45-8. PubMed ID: 27578036
[TBL] [Abstract][Full Text] [Related]
17. Current state of the art and emerging pharmacotherapy for uterine leiomyosarcomas.
Tantari M; Barra F; Di Domenico S; Ferraioli D; Vellone VG; De Cian F; Ferrero S
Expert Opin Pharmacother; 2019 Apr; 20(6):713-723. PubMed ID: 30724615
[TBL] [Abstract][Full Text] [Related]
18. Efficacy and toxicities of doxorubicin plus ifosfamide in the second-line treatment of uterine leiomyosarcoma.
Niu SY; Sun L; Hsu ST; Hwang SF; Liu CK; Shih YH; Lu TF; Chen YF; Lai LC; Chang PL; Lu CH
Front Oncol; 2023; 13():1282596. PubMed ID: 38090488
[TBL] [Abstract][Full Text] [Related]
19. Targeting Class I Histone Deacetylases in Human Uterine Leiomyosarcoma.
Yang Q; Falahati A; Khosh A; Mohammed H; Kang W; Corachán A; Bariani MV; Boyer TG; Al-Hendy A
Cells; 2022 Nov; 11(23):. PubMed ID: 36497061
[TBL] [Abstract][Full Text] [Related]
20. Evaluation of the efficacy of systemic therapy for advanced uterine leiomyosarcoma: A systematic review, meta-analysis, and meta-regression analysis.
Ijaz I; Shahzad MN; Hosseinifard H; Liu S; Sefidan MO; Kahloon LE; Imani S; Hua Z; Zhang YQ
Cancer Med; 2023 Jul; 12(13):13894-13911. PubMed ID: 37081717
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
